Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Chronic Lymphocytic Leukemia Patients. Show all posts
Showing posts with label Chronic Lymphocytic Leukemia Patients. Show all posts
Monday, February 2, 2026

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

›
In continuation of my update on  ibrutinib Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere...
Friday, October 11, 2019

AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients

›
In continuation of my update on  Venclexta (venetoclax) AbbVie a research-based global biopharmaceutical  company,  announced th...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.